"Pharmaceutical leader" microbial drug research set off an investment boom of 1.3 billion "Thunderbolt" in pharmaceutical enterprises!
-
Last Update: 2019-12-16
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
(December 16, 2019) the investment boom in microbial drug research has been raised for three years, with a financing of more than $947 million; baiaotai "adamumumab injection" on the Internet in Shanghai; Novo Nordisk accelerates the listing process of somaluptide in China by submitting five import clinical applications at one time; pharmaceutical companies have 1.3 billion "Thunderbolt"! This year, seven companies lost two or more than 1 billion yuan for the first time See who they are? Hume shivered High yield of Novo Nordisk It seems that the money is not enough Pharmaceutical companies are losing money What's the next step? It's gone forever that this kind of industry opportunity can earn hundreds of thousands of dollars a year by eating rice and drinking tea every day.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
